Nuvectis Pharma, Inc. (NVCT)
7.78
-0.20
(-2.51%)
USD |
NASDAQ |
Dec 19, 16:00
7.82
+0.04
(+0.51%)
After-Hours: 20:00
Nuvectis Pharma Shareholders Equity (Quarterly): 24.01M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 79.28B |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 35.59M |
| Total Liabilities (Quarterly) | 11.58M |
| Current Ratio | 3.074 |